FDA Inspection
Clario (BioClinica, Inc.)Clario (BioClinica, Inc.) – FDA Inspection, Apr 22, 2025
Record Details
This FDA Inspection record concerns Clario (BioClinica, Inc.), with an inspection on April 22, 2025, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · bbb1893a-002e-4247-9b16-d8366f4a3fc5
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1270798
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Clario (BioClinica, Inc.)
13| Date | Classification | Office | Project area |
|---|---|---|---|
| August 18, 2026 | Not classified | Philadelphia District Office | |
| July 30, 2026 | Not classified | Philadelphia District Office | |
| June 25, 2026 | Not classified | Philadelphia District Office | |
| April 22, 2026 | Not classified | Philadelphia District Office | |
| February 23, 2026 | Not classified | Philadelphia District Office |
Other documents for Clario (BioClinica, Inc.)
- FDA Inspection 1334408 - 2026-08-18
- FDA Inspection 1330718 - 2026-07-30
- FDA Inspection 1325092 - 2026-06-25
- FDA Inspection 1318274 - 2026-04-22
- FDA Inspection 1314940 - 2026-02-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.